ESTRO37_ProgrammeBook

SYMPOSIUM Improving radiation therapy in breast cancer by avoiding side effects 10:30 - 11:45  | ROOM 116 In this session we will address currently available and future approaches to decrease the risk for late side effects after radiation therapy for breast cancer. We will give insight into how to introduce respiratory control in your daily clinical practise and how to optimise the available technology to decrease the dose to organs at risk. The future might hold new applications in breast cancer treatment including protons, minibeams and very high dose rate delivery. As life can never be freed from any risks, we will finish with insights into radiation-induced cancers including possible interventions like smoking-cessation and the cost/benefit balance depending on risk factors.

SATURDAY 21 APRIL 2018

Chair: P. Poortmans (France) Co-Chair: I. Meattini (Italy)

10:30 > Cost-effective implementation of respiratory control for all! Speaker: A. Kirby (United Kingdom)

SP-0045

10:48 > Avoiding side effects: getting the best out of advanced delivery techniques Speaker: M. Aznar (United Kingdom) 11:06 > Between high-tech and biology: how to exploit protons, minibeams and flash irradiation to avoid toxicity? Speaker: A. Fourquet (France)

SP-0046

SP-0047

11:24 > Second cancers after radiotherapy for breast cancer Speaker: T. Grantzau (Denmark)

SP-0048

PROFFERED PAPERS RB 1: Joint efforts in Immuno-radiobiology 10:30 - 11:45  | ROOM 120-121 Chair: T. Illidge (United Kingdom) Chair: F. McDonald (United Kingdom)

10:30 > Genomic profiling of muscle invasive bladder cancer to predict response to chemoradiation therapy

D. Miyamoto (USA), E. Gibb, K. Mouw, Y. Liu, C. Wu, M. Drumm, J. Lehrer, H. Ashab, N. Erho, M. Du Plessis, K. Ong, W. Shipley, E. Davicioni, J. Efstathiou

OC-0049

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

76